Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Efficacy of a New Ovarian Stimulation Regimen With RANDom Start, Use of Corifollitropin Alpha and Progestin Protocol for Oocyte donorS

NCT03895099 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal Creteil as lead sponsor.

NCT NCT03895099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03895099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Efficacy of a New Ovarian Stimulation Regimen With RANDom Start, Use of Corifollitropin Alpha and Progestin Protocol for Oocyte donorS
Lead sponsor
Centre Hospitalier Intercommunal Creteil
Phase
Phase 3
Overall status
Completed
Start date
September 4, 2020
Completion date
October 30, 2023
Enrollment
110 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

infertility